Journal
MOLECULAR AND CELLULAR ENDOCRINOLOGY
Volume 276, Issue 1-2, Pages 63-70Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.mce.2007.06.007
Keywords
LH receptor; glycosylation; breast cancer; polymorphism
Categories
Ask authors/readers for more resources
Polymorphic variation of the LHR gene may affect receptor function and accordingly may influence ovarian steroid hormone action, including steroid hormone-dependent clinical outcome. The functional effects of two single nucleotide polymorphisms (SNPs), i.e. LHR 291 Asn/Ser (rs 12470652) and 312Ser/Asn (rs2293275) in the biologically interesting exon 10 of the LHR gene are described. Furthermore, ethnic diversity in allele frequencies and genotype distributions of both SNPs was determined. In addition associations with breast cancer were studied in 75 1 breast cancer patients. In vitro transfection studies revealed altered glycosylation status and increased receptor sensitivity for the 29 1 Ser LHR variant. No functional consequences were observed for the 312SerAsn LHR SNP. The LHR 312Asn allele was slightly more often present in two independent breast cancer patient cohorts as compared to controls (OR = 1. 15; p = 0.03 and 1.26; p = 0.00 1, respectively). In conclusion, although functional changes of the LHR 29 1 Ser candidate allele were observed, no associations with breast cancer were found, while the LHR 312Asn allele can be regarded as a weak breast cancer risk allele. (C) 2007 Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available